NCT04628182

Brief Summary

The main objective is to explore the current practice of right hemicolectomy for colon cancer located in the ascending colon and hepatic flexure in selected Chinese high quality and high volume centres. This study will identify a potential area to improve the level of standard care and serve as a reference cohort to which planned standardization and addition of innovative aspects can be compared to

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,579

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 9, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

November 13, 2020

Completed
10 months until next milestone

Study Start

First participant enrolled

September 1, 2021

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 28, 2022

Completed
2 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2022

Completed
Last Updated

June 30, 2022

Status Verified

June 1, 2022

Enrollment Period

10 months

First QC Date

November 9, 2020

Last Update Submit

June 28, 2022

Conditions

Right HemicolectomyColon Cancer

Outcome Measures

Primary Outcomes (1)

  • post-operative anastomotic leakages

    Number of post-operative anastomotic leakages within 30 days.

    1 month

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Participants with non-metastasized right sided colon cancer without ingrowth into other organs suitable for elective radical resection of the ascending colon.

You may qualify if:

  • Segmental right sided hemicolectomy (including extended)
  • Cancer stage 1-3 (CT-staged)
  • No prior abdominal surgery

You may not qualify if:

  • Stage cT4b, perforated disease
  • Acute obstruction
  • Emergency surgery
  • Right hemicolectomy or ileocaecal resection as part of a large procedure such as subtotal colectomy or panproctocolectomy
  • Patients with inflammatory bowel disease (Crohn's disease or ulcerative colitis)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Beijing Friendship Hospital

Beijing, Beijing Municipality, 100050, China

RECRUITING

MeSH Terms

Conditions

Colonic Neoplasms

Condition Hierarchy (Ancestors)

Colorectal NeoplasmsIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

November 9, 2020

First Posted

November 13, 2020

Study Start

September 1, 2021

Primary Completion

June 28, 2022

Study Completion

June 30, 2022

Last Updated

June 30, 2022

Record last verified: 2022-06

Locations

CN(1)